Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia
· Delayed Price · Currency is SAR 123.00
+0.80 (0.65%)
May 13, 2025, 3:19 PM AST
Nahdi Medical Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 9,824 | 9,446 | 8,714 | 8,616 | 8,066 | 8,642 | Upgrade
|
| Revenue Growth (YoY) | 10.80% | 8.41% | 1.13% | 6.82% | -6.67% | 10.45% | Upgrade
|
| Cost of Revenue | 6,005 | 6,005 | 5,278 | 5,141 | 4,821 | 5,448 | Upgrade
|
| Gross Profit | 3,819 | 3,441 | 3,436 | 3,475 | 3,245 | 3,194 | Upgrade
|
| Selling, General & Admin | 2,598 | 2,598 | 2,499 | 2,500 | 2,397 | 2,269 | Upgrade
|
| Other Operating Expenses | 339.19 | -27.91 | -23.7 | -24.3 | -58.06 | -23.08 | Upgrade
|
| Operating Expenses | 2,937 | 2,570 | 2,475 | 2,475 | 2,339 | 2,228 | Upgrade
|
| Operating Income | 882.01 | 871.66 | 960.74 | 999.82 | 905.94 | 966.17 | Upgrade
|
| Interest Expense | -73.72 | -73.72 | -50.46 | -50.47 | -78.88 | -57.5 | Upgrade
|
| Interest & Investment Income | 50.8 | 50.8 | 56.82 | 12.13 | 2.96 | 5.45 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.34 | 8.34 | 7.91 | 1.8 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -25.67 | -25.67 | -31.47 | -11.15 | 7.61 | 1.8 | Upgrade
|
| EBT Excluding Unusual Items | 841.76 | 831.41 | 943.53 | 952.13 | 837.63 | 915.92 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.54 | 1.54 | 0.22 | -17.37 | 0.15 | 1.13 | Upgrade
|
| Asset Writedown | 1.6 | 1.6 | 0.5 | 3.16 | 19.49 | -22.6 | Upgrade
|
| Pretax Income | 844.9 | 834.54 | 944.25 | 937.93 | 857.27 | 894.45 | Upgrade
|
| Income Tax Expense | 1.96 | 13.82 | 51.63 | 50.11 | 44.74 | 45.33 | Upgrade
|
| Net Income | 842.94 | 820.72 | 892.62 | 887.81 | 812.53 | 849.12 | Upgrade
|
| Net Income to Common | 842.94 | 820.72 | 892.62 | 887.81 | 812.53 | 849.12 | Upgrade
|
| Net Income Growth | -4.35% | -8.05% | 0.54% | 9.26% | -4.31% | 22.70% | Upgrade
|
| Shares Outstanding (Basic) | 130 | 130 | 130 | 130 | 130 | 130 | Upgrade
|
| Shares Outstanding (Diluted) | 130 | 130 | 130 | 130 | 130 | 130 | Upgrade
|
| Shares Change (YoY) | 0.01% | - | - | - | - | 2500.00% | Upgrade
|
| EPS (Basic) | 6.48 | 6.31 | 6.87 | 6.83 | 6.25 | 6.53 | Upgrade
|
| EPS (Diluted) | 6.48 | 6.31 | 6.87 | 6.83 | 6.25 | 6.53 | Upgrade
|
| EPS Growth | -4.35% | -8.05% | 0.54% | 9.26% | -4.31% | -95.28% | Upgrade
|
| Free Cash Flow | 1,321 | 1,152 | 962.17 | 1,418 | 1,051 | 1,290 | Upgrade
|
| Free Cash Flow Per Share | 10.16 | 8.86 | 7.40 | 10.90 | 8.09 | 9.92 | Upgrade
|
| Dividend Per Share | - | 5.500 | 5.500 | 5.310 | - | - | Upgrade
|
| Dividend Growth | - | - | 3.58% | - | - | - | Upgrade
|
| Gross Margin | 38.87% | 36.43% | 39.43% | 40.33% | 40.23% | 36.96% | Upgrade
|
| Operating Margin | 8.98% | 9.23% | 11.03% | 11.60% | 11.23% | 11.18% | Upgrade
|
| Profit Margin | 8.58% | 8.69% | 10.24% | 10.30% | 10.07% | 9.83% | Upgrade
|
| Free Cash Flow Margin | 13.45% | 12.19% | 11.04% | 16.45% | 13.04% | 14.93% | Upgrade
|
| EBITDA | 1,146 | 1,130 | 1,181 | 1,192 | 1,070 | 1,110 | Upgrade
|
| EBITDA Margin | 11.66% | 11.96% | 13.55% | 13.84% | 13.26% | 12.84% | Upgrade
|
| D&A For EBITDA | 263.73 | 258.31 | 219.86 | 192.36 | 164.03 | 143.75 | Upgrade
|
| EBIT | 882.01 | 871.66 | 960.74 | 999.82 | 905.94 | 966.17 | Upgrade
|
| EBIT Margin | 8.98% | 9.23% | 11.03% | 11.60% | 11.23% | 11.18% | Upgrade
|
| Effective Tax Rate | 0.23% | 1.66% | 5.47% | 5.34% | 5.22% | 5.07% | Upgrade
|
| Advertising Expenses | - | 59.61 | 66.36 | 67.81 | 54.92 | 75.69 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.